Zhong Huijuan is Chairwoman and Chief Executive Officer of Hansoh Pharmaceutical Group, a leading innovation‑driven biopharmaceutical company headquartered in China. She founded the company in 1995 and has overseen its strategic growth from a small regional firm into a major global pharmaceutical enterprise. Under her leadership, Hansoh has focused on research and development in therapeutic areas including oncology, anti‑infections, central nervous system diseases, metabolic disorders and autoimmune diseases, advancing a robust pipeline that includes more than 70 clinical trials and multiple innovative drugs generating sales revenue.
During her tenure, Hansoh Pharmaceutical has transitioned into a highly competitive, innovation‑oriented biopharma company with several internally developed medicines included in China’s National Reimbursement Drug List and advanced collaborations with international partners. The company’s manufacturing quality systems are certified by major regulatory authorities including the U.S. FDA, the EU’s EMA and Japan’s PMDA, and Hansoh’s expanding global footprint includes licensing and development collaborations on investigational treatments for cancer and other serious diseases.
The 100 CEOs featured here reflect the diversity and complexity of modern oncology leadership. In 2025, some lead the world’s largest cancer institutions; others guide specialized societies or emerging innovators. What unites them is responsibility: for millions of patients, for the integrity of science, and for the future direction of cancer care globally.
This list is not a celebration of power, but a recognition of stewardship, accountability, and impact – and of the leaders whose choices continue to shape the fight against cancer. For the many deserving individuals not mentioned in this list, we will continue to acknowledge, honor and elevate your voices in our daily publications from across the world.
See the full list of The 100 Most Influential CEOs in Oncology in 2025, and stay tuned for other special category nominations.
